Asedebart is an investigational monoclonal antibody designed to neutralize excess adrenocorticotropic hormone (ACTH) and reduce downstream cortisol production in Cushing's disease (CD)Urinary free cortisol (UFC) normalization is a clinically relevant measure in CD, where chronic cortisol excess is…
News provided by PR Newswire.
